Abbott Laboratories has reported an increase in nine-month sales from its nutrition division as recently-launched infant formula and Ensure adult nutrition drinks boosted third-quarter revenue.

The maker of Eleva and Similac infant formula saw sales from its nutrition business, excluding foreign exchange, grow 3.7% in the nine months to the end of September. On a reported basis, which includes the impact of exchange rates, sales increased 2.2% to to US$5.15bn.

By segment, Abbott saw infant formula sales inch up 0.8%, excluding currency fluctuation, over the nine months. However, including exchange rates, revenue fell 0.6% to $2.84bn.

The US group’s adult nutrition arm enjoyed faster growth, with sales up 7.7% excluding currency and rising 5.9% to $2.31bn on a reported basis.

Both divisions saw sales accelerate in the third quarter. Looking at the numbers excluding currency, Abbott’s paediatric sales were up 8.6%. The company pointed to the impact of the launches of Eleva and Similac Qinti infant formula in China.

The company’s adult nutrition business saw sales climb 11.8%. It cited “strong growth” from the Ensure brand.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Click here for the full results.

Just Food Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Just Food Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now